06 dec: SimCorps Finanskalender 2017
06 dec: Finanskalender 2017
06-12-2016 15:16:09

Chr. Hansen Holding A/S appoints new Chief Scientific Officer

Relateret indhold
16 feb - 
Danone ser fortsat vækst i indtjeningen efter fremgang ..
14 feb - 
Chr. Hansen-konkurrent både sælger og tjener over forve..
07 feb - 
Aktier/middag: Lundbeck og Novozymes i top og bund efte..
Relateret debat
13 feb - 
Nej, det er int' noget man sår'n jaw'er te' siger min l..
13 feb - 
Tak Alpe har du købt :-)
13 feb - 
Tak ;-)

Hoersholm, 2016-12-06 15:16 CET (GLOBE NEWSWIRE) --

 

Company announcement No. 25/2016

Chr. Hansen Holding A/S has entered into an agreement with Thomas Schäfer to take up the position of Executive Vice President and Chief Scientific Officer.

Thomas is currently employed as Vice President at Novozymes and will take up his new position as soon as possible, which is expected to be during spring 2017.

A German national, Thomas completed his Ph.D. in Microbiology, Physiology & Biochemistry and worked as an assistant professor at Freie Universität Berlin. He started his commercial career as a post doc and has since 1994 held various senior leadership positions in the R&D space at Novozymes.

Thomas has more than 20 years’ experience in industrial microbiology, R&D, Innovation, business development and M&A, covering both bacteria and enzymes. He has published several papers, and is the co-founder of a number of patents.

Cees de Jong, CEO of Chr. Hansen, says: “I’m pleased to welcome Thomas to Chr. Hansen as we continue to strengthen our capabilities within the microbial platform and our leadership position in bacterial fermentation technology.”

Following this appointment, the Executive Board will consist of: CEO Cees de Jong, CFO Søren Westh Lonning, COO Knud Vindfeldt, and CSO Thomas Schäfer.

 

For further information, please contact:

Anders Mohr Christensen, Senior Director, Investor Relations

Tel: +45 4574 7618

Camilla Lercke, Head of Media Relations

Tel: +45 5339 2384

 

About Chr. Hansen

Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2015/16 financial year was EUR 949 million. The company has more than 2,700 dedicated employees in 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on Nasdaq Copenhagen A/S. For further information, please visit www.chr-hansen.com.

Vedhæftet fil: No 25 2016 US.pdf

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Vestas/Sydbank: Stigende tyske priser er rigtig godt nyt

20-02-2018 14:01:42
Vestas-aktien er tirsdag eftermiddag gået i front for C25-indekset, efter at resultatet fra den seneste tyske auktion over vindprojekter på land har resulteret i noget højere priser, end tilfældet var ved den foregående auktion.Og det er helt naturligt, at aktien stiger på nyheden, der umiddelbart er rigtig positiv for Vestas og de øvrige vindmølleproducenter.- Vestas har selv nævnt udbudspriserne..

Aktier/middag: Mærsk trækker C25 i rødt med nyt fra kapitalmarkedsdag

20-02-2018 11:42:02
De danske eliteaktier er delt nogenlunde på midten tirsdag formiddag, men Mærsk-aktierne agerer tunge lodder i bunden, som trækker det samlede C25-indeks ned i et mindre fald på 0,5 pct. til 1126,09.Mærsk holder kapitalmarkedsdag tirsdag i København, og de oplysninger, der indtil nu er sluppet ud fra Operaen, har tilsyneladende ikke opmuntret investorerne, der sender Mærsk-aktierne ned.Generelt er..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Vestas/Sydbank: Stigende tyske priser er rigtig godt nyt
2
Danske Bank foreslår topchefernes skræk til bestyrelsen
3
KORR: Novo/Kepler: Hæver kursmål og fastholder "hold"
4
Aktier/middag: Mærsk trækker C25 i rødt med nyt fra kapitalmarkedsdag
5
Pandora: Kæmpe kapitalforvalter spekulerer et nøk mindre i kursfald

Relaterede aktiekurser

Chr Hansen Holding A/S 517,60 0,0% Aktiekurs uændret

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2018  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
21. februar 2018 02:37:54
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20180219.1 - EUROWEB7 - 2018-02-21 02:37:54 - 2018-02-21 02:37:54 - 1 - Website: OKAY